General Archive

Home » Motor neuron disease & rare dementias » Page 3
  • 3D illustration of neurons of Dorsal striatum

    MND STaR: Validating therapeutic targets for motor neuron disease with King’s College London 

    Validating therapeutic targets for motor neuron disease with King’s College London  We have teamed up with King’s College London (King’s)…

    Read more

  • Degradation of motor neurons, conceptual 3D illustration.
    News releases

    £76M investment backing into potential MND treatment, underlines benefit of charity funding

    Promising new research to develop gene therapy to treat motor neuron disease and other conditions like dementia secures big investment…

    Read more

  • Collage of photographs from a conference about ALS. Images feature people chatting, brochures and someone delivering a talk

    ALS Therapy Development Institute Summit

    About the event The ALS TDI Summit is a free conference that aims to inform and empower the ALS community…

    Read more

  • A portrait cover image of Manuela Cerina, Scientific Director at LifeArc.
    News releases

    New partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development

    LifeArc and ALS Therapy Development Institute (ALS TDI) have joined forces to identify, validate, and develop new biomarkers that are…

    Read more

  • 3D illustration of a synapse and Neuron cells sending electrical chemical signals.
    News releases

    LifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation

    LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London (KCL) to validate a…

    Read more

  • 3D illustration of a synapse and Neuron cells sending electrical chemical signals.

    NEURii: Transforming care for people living with dementia throughUK-based collaboration

    NEURii: Transforming care for people living with dementia through UK-based collaboration In partnership with Eisai, Gates Ventures, Health Data Research…

    Read more

  • A male LifeArc scientists wearing gloves, a lab coat and safety glasses, pipettes liquid into a clear beaker.

    UKDRI: A £30 million partnership for the development of new dementia treatments

    UK DRI: A £30 million partnership for the development of new dementia treatments Our partnership with the UK Dementia Research…

    Read more

  • Two hands cradle a string of paper dolls including children and adults, one is a wheelchair user.

    MND Insights Group: Collaborating with the MND community to understand urgent needs

    MND Insights Group: Collaborating with the MND community to understand urgent needs At LifeArc our mission is to uncover the…

    Read more

  • The MND collaborative partnership

    The MND collaborative partnership £4.25 million partnership aimed at speeding up the development of effective MND treatments. Overview This exciting…

    Read more

  • A female LifeArc scientist in gloves, lab coat, hijab and safety glasses lifts a plate from a lab machine.

    Funding: Development of repurposed drug candidates for MND

    Funding: Development of repurposed drug candidates for MND Through LifeArc’s Translational Challenge in MND, this funding programme aims to boost…

    Read more

  • A LifeArc scientist operates chemistry equipment behind a protective screen.

    Funding: £1m primer fund to accelerate MND diagnosis

    Funding: £1m primer fund to accelerate MND diagnosis The primer fund is intended to support projects which seek to develop…

    Read more

  • Close up of cell images on a computer screen in the lab, with and male and female scientist in the foreground

    Funding: The MND translational research fund

    Funding: The MND translational research fund A joint fund created by LifeArc and the Motor Neurone Disease Association (MND Association)…

    Read more